The global Alzheimer Disease Genetic Testing market was valued at US$ 115.2 million in 2023 and is projected to reach US$ 358.7 million by 2030, at a CAGR of 17.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Early-Onset Alzheimer Disease Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Alzheimer Disease Genetic Testing include Mega Genomics, Blueprint Genetics, Generi-Biotech, RxHomeTest, Kashi Labs, 23andMe, LabCorp, Empower DX and SolGent, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Alzheimer's disease is a neurodegenerative disorder that affects memory, cognitive functions, and behavior. While there is no cure for Alzheimer's disease, early detection and treatment can help slow the progression of the disease. Genetic testing can be a useful tool in identifying individuals who may be at higher risk of developing Alzheimer's disease.
This report aims to provide a comprehensive presentation of the global market for Alzheimer Disease Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer Disease Genetic Testing. This report contains market size and forecasts of Alzheimer Disease Genetic Testing in global, including the following market information:
- Global Alzheimer Disease Genetic Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the Alzheimer Disease Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer Disease Genetic Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Alzheimer Disease Genetic Testing Market Segment Percentages, by Type, 2023 (%)
- Early-Onset Alzheimer Disease
- Late-Onset Alzheimer Disease
Global Alzheimer Disease Genetic Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Alzheimer Disease Genetic Testing Market Segment Percentages, by Application, 2023 (%)
Global Alzheimer Disease Genetic Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Alzheimer Disease Genetic Testing Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer Disease Genetic Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Alzheimer Disease Genetic Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Mega Genomics
- Blueprint Genetics
- Generi-Biotech
- RxHomeTest
- Kashi Labs
- 23andMe
- LabCorp
- Empower DX
- SolGent
- CapitalBio
- Genex Diagnostics
- Sansure
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Alzheimer Disease Genetic Testing, market overview.
- Chapter 2: Global Alzheimer Disease Genetic Testing market size in revenue.
- Chapter 3: Detailed analysis of Alzheimer Disease Genetic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Alzheimer Disease Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Alzheimer Disease Genetic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alzheimer Disease Genetic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alzheimer Disease Genetic Testing Overall Market Size
2.1 Global Alzheimer Disease Genetic Testing Market Size: 2023 VS 2030
2.2 Global Alzheimer Disease Genetic Testing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alzheimer Disease Genetic Testing Players in Global Market
3.2 Top Global Alzheimer Disease Genetic Testing Companies Ranked by Revenue
3.3 Global Alzheimer Disease Genetic Testing Revenue by Companies
3.4 Top 3 and Top 5 Alzheimer Disease Genetic Testing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Alzheimer Disease Genetic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alzheimer Disease Genetic Testing Players in Global Market
3.6.1 List of Global Tier 1 Alzheimer Disease Genetic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Alzheimer Disease Genetic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Alzheimer Disease Genetic Testing Market Size Markets, 2023 & 2030
4.1.2 Early-Onset Alzheimer Disease
4.1.3 Late-Onset Alzheimer Disease
4.2 By Type - Global Alzheimer Disease Genetic Testing Revenue & Forecasts
4.2.1 By Type - Global Alzheimer Disease Genetic Testing Revenue, 2019-2024
4.2.2 By Type - Global Alzheimer Disease Genetic Testing Revenue, 2025-2030
4.2.3 By Type - Global Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alzheimer Disease Genetic Testing Market Size, 2023 & 2030
5.1.2 Online
5.1.3 Offline
5.2 By Application - Global Alzheimer Disease Genetic Testing Revenue & Forecasts
5.2.1 By Application - Global Alzheimer Disease Genetic Testing Revenue, 2019-2024
5.2.2 By Application - Global Alzheimer Disease Genetic Testing Revenue, 2025-2030
5.2.3 By Application - Global Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Alzheimer Disease Genetic Testing Market Size, 2023 & 2030
6.2 By Region - Global Alzheimer Disease Genetic Testing Revenue & Forecasts
6.2.1 By Region - Global Alzheimer Disease Genetic Testing Revenue, 2019-2024
6.2.2 By Region - Global Alzheimer Disease Genetic Testing Revenue, 2025-2030
6.2.3 By Region - Global Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Alzheimer Disease Genetic Testing Revenue, 2019-2030
6.3.2 US Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.3.3 Canada Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.3.4 Mexico Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Alzheimer Disease Genetic Testing Revenue, 2019-2030
6.4.2 Germany Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.4.3 France Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.4.4 U.K. Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.4.5 Italy Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.4.6 Russia Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.4.7 Nordic Countries Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.4.8 Benelux Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Alzheimer Disease Genetic Testing Revenue, 2019-2030
6.5.2 China Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.5.3 Japan Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.5.4 South Korea Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.5.5 Southeast Asia Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.5.6 India Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Alzheimer Disease Genetic Testing Revenue, 2019-2030
6.6.2 Brazil Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.6.3 Argentina Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alzheimer Disease Genetic Testing Revenue, 2019-2030
6.7.2 Turkey Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.7.3 Israel Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.7.4 Saudi Arabia Alzheimer Disease Genetic Testing Market Size, 2019-2030
6.7.5 UAE Alzheimer Disease Genetic Testing Market Size, 2019-2030
7 Alzheimer Disease Genetic Testing Companies Profiles
7.1 Mega Genomics
7.1.1 Mega Genomics Company Summary
7.1.2 Mega Genomics Business Overview
7.1.3 Mega Genomics Alzheimer Disease Genetic Testing Major Product Offerings
7.1.4 Mega Genomics Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.1.5 Mega Genomics Key News & Latest Developments
7.2 Blueprint Genetics
7.2.1 Blueprint Genetics Company Summary
7.2.2 Blueprint Genetics Business Overview
7.2.3 Blueprint Genetics Alzheimer Disease Genetic Testing Major Product Offerings
7.2.4 Blueprint Genetics Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.2.5 Blueprint Genetics Key News & Latest Developments
7.3 Generi-Biotech
7.3.1 Generi-Biotech Company Summary
7.3.2 Generi-Biotech Business Overview
7.3.3 Generi-Biotech Alzheimer Disease Genetic Testing Major Product Offerings
7.3.4 Generi-Biotech Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.3.5 Generi-Biotech Key News & Latest Developments
7.4 RxHomeTest
7.4.1 RxHomeTest Company Summary
7.4.2 RxHomeTest Business Overview
7.4.3 RxHomeTest Alzheimer Disease Genetic Testing Major Product Offerings
7.4.4 RxHomeTest Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.4.5 RxHomeTest Key News & Latest Developments
7.5 Kashi Labs
7.5.1 Kashi Labs Company Summary
7.5.2 Kashi Labs Business Overview
7.5.3 Kashi Labs Alzheimer Disease Genetic Testing Major Product Offerings
7.5.4 Kashi Labs Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.5.5 Kashi Labs Key News & Latest Developments
7.6 23andMe
7.6.1 23andMe Company Summary
7.6.2 23andMe Business Overview
7.6.3 23andMe Alzheimer Disease Genetic Testing Major Product Offerings
7.6.4 23andMe Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.6.5 23andMe Key News & Latest Developments
7.7 LabCorp
7.7.1 LabCorp Company Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Alzheimer Disease Genetic Testing Major Product Offerings
7.7.4 LabCorp Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.7.5 LabCorp Key News & Latest Developments
7.8 Empower DX
7.8.1 Empower DX Company Summary
7.8.2 Empower DX Business Overview
7.8.3 Empower DX Alzheimer Disease Genetic Testing Major Product Offerings
7.8.4 Empower DX Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.8.5 Empower DX Key News & Latest Developments
7.9 SolGent
7.9.1 SolGent Company Summary
7.9.2 SolGent Business Overview
7.9.3 SolGent Alzheimer Disease Genetic Testing Major Product Offerings
7.9.4 SolGent Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.9.5 SolGent Key News & Latest Developments
7.10 CapitalBio
7.10.1 CapitalBio Company Summary
7.10.2 CapitalBio Business Overview
7.10.3 CapitalBio Alzheimer Disease Genetic Testing Major Product Offerings
7.10.4 CapitalBio Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.10.5 CapitalBio Key News & Latest Developments
7.11 Genex Diagnostics
7.11.1 Genex Diagnostics Company Summary
7.11.2 Genex Diagnostics Business Overview
7.11.3 Genex Diagnostics Alzheimer Disease Genetic Testing Major Product Offerings
7.11.4 Genex Diagnostics Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.11.5 Genex Diagnostics Key News & Latest Developments
7.12 Sansure
7.12.1 Sansure Company Summary
7.12.2 Sansure Business Overview
7.12.3 Sansure Alzheimer Disease Genetic Testing Major Product Offerings
7.12.4 Sansure Alzheimer Disease Genetic Testing Revenue in Global Market (2019-2024)
7.12.5 Sansure Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Alzheimer Disease Genetic Testing Market Opportunities & Trends in Global Market
Table 2. Alzheimer Disease Genetic Testing Market Drivers in Global Market
Table 3. Alzheimer Disease Genetic Testing Market Restraints in Global Market
Table 4. Key Players of Alzheimer Disease Genetic Testing in Global Market
Table 5. Top Alzheimer Disease Genetic Testing Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Alzheimer Disease Genetic Testing Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Alzheimer Disease Genetic Testing Revenue Share by Companies, 2019-2024
Table 8. Global Companies Alzheimer Disease Genetic Testing Product Type
Table 9. List of Global Tier 1 Alzheimer Disease Genetic Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer Disease Genetic Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Alzheimer Disease Genetic Testing Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Alzheimer Disease Genetic Testing Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Alzheimer Disease Genetic Testing Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Alzheimer Disease Genetic Testing Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Alzheimer Disease Genetic Testing Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Alzheimer Disease Genetic Testing Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 30. Mega Genomics Company Summary
Table 31. Mega Genomics Alzheimer Disease Genetic Testing Product Offerings
Table 32. Mega Genomics Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 33. Mega Genomics Key News & Latest Developments
Table 34. Blueprint Genetics Company Summary
Table 35. Blueprint Genetics Alzheimer Disease Genetic Testing Product Offerings
Table 36. Blueprint Genetics Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 37. Blueprint Genetics Key News & Latest Developments
Table 38. Generi-Biotech Company Summary
Table 39. Generi-Biotech Alzheimer Disease Genetic Testing Product Offerings
Table 40. Generi-Biotech Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 41. Generi-Biotech Key News & Latest Developments
Table 42. RxHomeTest Company Summary
Table 43. RxHomeTest Alzheimer Disease Genetic Testing Product Offerings
Table 44. RxHomeTest Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 45. RxHomeTest Key News & Latest Developments
Table 46. Kashi Labs Company Summary
Table 47. Kashi Labs Alzheimer Disease Genetic Testing Product Offerings
Table 48. Kashi Labs Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 49. Kashi Labs Key News & Latest Developments
Table 50. 23andMe Company Summary
Table 51. 23andMe Alzheimer Disease Genetic Testing Product Offerings
Table 52. 23andMe Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 53. 23andMe Key News & Latest Developments
Table 54. LabCorp Company Summary
Table 55. LabCorp Alzheimer Disease Genetic Testing Product Offerings
Table 56. LabCorp Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 57. LabCorp Key News & Latest Developments
Table 58. Empower DX Company Summary
Table 59. Empower DX Alzheimer Disease Genetic Testing Product Offerings
Table 60. Empower DX Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 61. Empower DX Key News & Latest Developments
Table 62. SolGent Company Summary
Table 63. SolGent Alzheimer Disease Genetic Testing Product Offerings
Table 64. SolGent Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 65. SolGent Key News & Latest Developments
Table 66. CapitalBio Company Summary
Table 67. CapitalBio Alzheimer Disease Genetic Testing Product Offerings
Table 68. CapitalBio Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 69. CapitalBio Key News & Latest Developments
Table 70. Genex Diagnostics Company Summary
Table 71. Genex Diagnostics Alzheimer Disease Genetic Testing Product Offerings
Table 72. Genex Diagnostics Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 73. Genex Diagnostics Key News & Latest Developments
Table 74. Sansure Company Summary
Table 75. Sansure Alzheimer Disease Genetic Testing Product Offerings
Table 76. Sansure Alzheimer Disease Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 77. Sansure Key News & Latest Developments
List of Figures
Figure 1. Alzheimer Disease Genetic Testing Segment by Type in 2023
Figure 2. Alzheimer Disease Genetic Testing Segment by Application in 2023
Figure 3. Global Alzheimer Disease Genetic Testing Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Alzheimer Disease Genetic Testing Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Alzheimer Disease Genetic Testing Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alzheimer Disease Genetic Testing Revenue in 2023
Figure 8. By Type - Global Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 9. By Application - Global Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 10. By Type - Global Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 12. By Application - Global Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 14. By Region - Global Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 15. By Country - North America Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 16. US Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 20. Germany Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 21. France Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 28. China Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 32. India Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 34. Brazil Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Alzheimer Disease Genetic Testing Revenue Market Share, 2019-2030
Figure 37. Turkey Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Alzheimer Disease Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 41. Mega Genomics Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Blueprint Genetics Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Generi-Biotech Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. RxHomeTest Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Kashi Labs Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. 23andMe Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. LabCorp Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Empower DX Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. SolGent Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. CapitalBio Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Genex Diagnostics Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Sansure Alzheimer Disease Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
